868 related items for PubMed ID: 10653049
1. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[Abstract] [Full Text] [Related]
2. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
Can Respir J; 1999 Dec; 6(1):45-51. PubMed ID: 10202220
[Abstract] [Full Text] [Related]
3. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma.
Van den Berg NJ, Ossip MS, Hederos CA, Anttila H, Ribeiro BL, Davies PI.
Pediatr Pulmonol; 2000 Aug; 30(2):97-105. PubMed ID: 10922131
[Abstract] [Full Text] [Related]
4. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
Bateman ED, Silins V, Bogolubov M.
Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
[Abstract] [Full Text] [Related]
5. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
[Abstract] [Full Text] [Related]
6. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[Abstract] [Full Text] [Related]
7. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A, Jacques L, Frith L.
Clin Drug Investig; 2008 Mar; 28(3):169-81. PubMed ID: 18266402
[Abstract] [Full Text] [Related]
8. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A, Jarvis B.
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[Abstract] [Full Text] [Related]
9. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW.
J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
[Abstract] [Full Text] [Related]
10. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
11. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[Abstract] [Full Text] [Related]
12. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.
Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T.
Chest; 2003 Sep; 124(3):834-43. PubMed ID: 12970006
[Abstract] [Full Text] [Related]
13. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[Abstract] [Full Text] [Related]
14. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
[Abstract] [Full Text] [Related]
15. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma.
Bergmann KC, Lindemann L, Braun R, Steinkamp G.
Swiss Med Wkly; 2004 Jan 24; 134(3-4):50-8. PubMed ID: 14745658
[Abstract] [Full Text] [Related]
16. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
Kuna P.
Clin Drug Investig; 2010 Jan 24; 30(9):565-79. PubMed ID: 20593912
[Abstract] [Full Text] [Related]
17. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J, Murray JJ, Nathan RA, Berger WE, Johnson M, Edwards LD, Srebro S, Rickard KA.
Chest; 1999 Sep 24; 116(3):625-32. PubMed ID: 10492263
[Abstract] [Full Text] [Related]
18. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.
Shapiro G, Lumry W, Wolfe J, Given J, White MV, Woodring A, Baitinger L, House K, Prillaman B, Shah T.
Am J Respir Crit Care Med; 2000 Feb 24; 161(2 Pt 1):527-34. PubMed ID: 10673196
[Abstract] [Full Text] [Related]
19. Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma.
Chan R, Sousa AR, Mallett S, Hynds P, Homayoun-Valiani F, Tabberer M, Mehta R.
Pulm Pharmacol Ther; 2016 Dec 24; 41():19-24. PubMed ID: 27599598
[Abstract] [Full Text] [Related]
20. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM.
Chest; 2000 Aug 24; 118(2):303-12. PubMed ID: 10936117
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
